Company Overview and News

Spirit Airlines Incorporated Stock Could Benefit from the Southwest Effect

2018-04-18 investorplace
Spirit Airlines Incorporated (NYSE:SAVE) continues to make waves in the airline industry. Although employee issues and complaints of poor service plague the airline’s image, Spirit stock continues to impress investors.
Upvote Downvote

Avoid United Continental Holdings Inc Stock Despite Earnings Beat

2018-04-18 investorplace
Although United Continental Holdings Inc (NYSE:UAL) earnings weren’t hurt by another public relations debacle, United stock just isn’t a safe bet. The company again finds itself suffering from negative press after a dog died in one of its overhead compartments.
Upvote Downvote

Spirit Airlines, Inc. Announces Webcast of First Quarter 2018 Results

2018-04-17 globenewswire
MIRAMAR, Fla., April 17, 2018 (GLOBE NEWSWIRE) -- Spirit Airlines, Inc. (NYSE:SAVE) will hold a conference call to discuss first quarter 2018 results on April 26, 2018 at 9:30 a.m. ET. A live, listen-only webcast of the conference call will be available at Any changes to the Company's scheduled presentation time will be posted on its website under the Investor Relations section at http://ir.
Upvote Downvote

What's Behind the 3.1% Dip in Allegiant Travel (ALGT) Stock?

2018-04-17 zacks
Shares of Allegiant Travel Company (ALGT - Free Report) — the parent company of Allegiant Airlines — declined 3.1% on Apr 16, closing the trading session at $146.40. A television program aired on Apr 15 highlighting the multiple mechanical problems on Allegiant’s flights, contributed to this sharp decline. Earlier, the Allegiant stock had slipped further to the tune of 8.6% on Apr 13, following reports that the show will be telecast in two days’ time.
Upvote Downvote

J. B. Hunt's (JBHT) Q1 Earnings Miss, Revenues Beat, Rise Y/Y

2018-04-16 zacks
J.B. Hunt Transport Services, Inc. (JBHT - Free Report) reported mixed results in the first quarter of 2018. While the company posted better-than-expected revenues, earnings per share lagged expectations in the quarter.
Upvote Downvote

Delta (DAL) Q1 Earnings Top Estimates, Down Y/Y on High Costs

2018-04-12 zacks
Delta Air Lines Inc. (DAL - Free Report) kicked off first-quarter 2018 earnings season for the airline space on a bright note. The company’s earnings as well as revenues surpassed the Zacks Consensus Estimate in the quarter.
Upvote Downvote

SAVE / Spirit Airlines, Inc. 8-K (Current Report)

Upvote Downvote

Business News Roundup, April 10

2018-04-09 sfgate
The combined effect of President Trump’s tax cuts and last month’s budget-busting spending bill is sending the government’s budget deficit toward the $1 trillion mark next year, according to a new analysis by the Congressional Budget Office.
Upvote Downvote

US airline industry boasts overall improvements: study - Channel NewsAsia

2018-04-09 channelnewsasia
Despite a steady stream of headlines highlighting U.S. airlines' customer-service failures, carriers have actually improved in several key areas over the last year, including bumping fewer passengers and losing less baggage, according to a study released on Monday.
Upvote Downvote

U.S. airline industry boasts overall improvements -study

2018-04-09 reuters
NEW YORK (Reuters) - Despite a steady stream of headlines highlighting U.S. airlines’ customer-service failures, carriers have actually improved in several key areas over the last year, including bumping fewer passengers and losing less baggage, according to a study released on Monday.
Upvote Downvote

5 Airline Stocks Poised to Beat Earnings Estimates in Q1

2018-04-09 zacks
The current projection for Q1 earnings season is very encouraging. Per the latest earnings preview, the bottom line for S&P 500 companies is expected to expand at a highly impressive rate of 16% on a year-over-year basis. Total revenues for the same set of companies are projected to grow 7.4%. The report further predicts that 14 of the 16 Zacks sectors will end the Q1 earnings season with the bottom line improving year over year.
Upvote Downvote

America’s Best Airlines in 2018

2018-04-06 247wallst
Long one of the lowest rated of all U.S. industries, the country’s airlines have made something of a comeback over the past four years. In 2013 airlines scored just ahead of internet services providers (ISPs) and cable TV providers at the bottom of the rankings maintained by the American Customer Satisfaction Index. Airlines’ scores improved by 4.2% last year and now rank ahead of 10 services, including ISPs and cable guys (still at the bottom), fixed-line phone services, wireless phone service and health insurers.
Upvote Downvote

Airline Stocks Offer a Ray of Hope After Monday's Slump

2018-04-04 zacks
The airline companies heaved a sigh of relief post Monday’s dramatic fall. This is because shares of key airline players rose yesterday, signaling a big upside and a healthy first-quarter 2018. Sector participants, namely Delta Air Lines, Inc. (DAL - Free Report) , United Continental Holdings, Inc. (UAL - Free Report) , American Airlines Group Inc. (AAL - Free Report) , Southwest Airlines Co. (LUV - Free Report) , Alaska Air Group, Inc.
Upvote Downvote

Why Airlines Tanked After DOT's Tentative Cuban Clearance

2018-04-03 zacks
Airline stocks made a nightmarish start to this week with key companies like Delta Air Lines, Inc. (DAL - Free Report) , American Airlines Group Inc. (AAL - Free Report) ,United Continental Holdings, Inc. (UAL - Free Report) , Alaska Air Group, Inc. (ALK - Free Report) and Southwest Airlines Co. (LUV - Free Report) witnessing steep declines in stock prices on Apr 2. Naturally, the sector tracker — NYSE ARCA Airline Index — also decreased significantly (to the tune of 3.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 848577102